JOSHUA GREENE: Open Payments
NPI 1639849599 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 7 payments from 7 companies in 2025. Trend: 2023 $164 · 2024 $208 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Corium, LLC | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, Auvelity, Azstarys, INGREZZA, FANAPT, ERZOFRI EXTENDED-RELEASE, REXULTI.
Industry payments across IN — which companies pay providers there.
